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Abstract
Background: The data arising from a longitudinal familial study have a complex correlation
structure that cannot be modeled using classical methods for the analysis of familial data at a single
time point.
Methods: To fit the longitudinal systolic blood pressure (SBP) pedigree data arising from the
Framingham Heart Study, we proposed to use multilevel modeling. That approach was used to
distinguish multiple levels of information with individual repeated measurements (Level 1) being
made within individuals (Level 2), and individuals clustered within pedigrees (Level 3). Residuals
from the subject-specific and pedigree-specific regression models were summed both for the mean
SBP and slope of SBP change over time, in order to define two new outcomes that were then used
in a genome-wide linkage analysis.
Results: Evidence for linkage for the two outcomes (mean SBP and slope) was found in several
chromosomal regions with a maximum LOD score of 3.6 on chromosome 8 and 3.5 on
chromosome 17 for the mean SBP, and 2.5 on chromosome 1 for SBP slope. However, the linkage
on chromosome 8 was only detected when the sample was restricted to subjects between age 25
and 75 and with at least four exams (Cohort 1) or 3 exams (Cohort 2).
Discussion: Multilevel modeling is a powerful approach to detect genes involved in complex traits
when longitudinal data are available. It allows for complex hierarchical data structure to be taken
into account and therefore, a better partitioning of random within-individual variation from other
sources of variability (genetic or nongenetic).
Background
The Framingham Heart Study provides long-term
repeated measurements of blood pressure and other phe-
notypes in two large cohorts of related individuals. Longi-
tudinal studies are efficient designs for the investigation of
individual changes over time. In the context of familial
studies, such designs might be of particular interest to
assess the proportion of the trait variability explained by
within-individual variation or other sources of variation.
However, the data arising from a longitudinal familial
study have a complex correlation structure that cannot be
modeled using classical methods for the analysis of famil-
ial data at a single time point. In this study, we proposed
to use multilevel modeling to fit the complex data struc-
ture arising from the Framingham Heart Study. Multilevel
modeling, also known as hierarchical regression,
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generalizes ordinary regression modeling to distinguish
multiple levels of information in a model [1]. It might be
appropriate to model the Framingham Heart Study data
that form a natural hierarchy with individual repeated
measurements (Level 1) being made within individuals
(Level 2), and individuals clustered within pedigrees
(Level 3). The use of appropriate random effects at each
level allows one to adjust for the influence of a wide vari-
ety of correlation structures and to estimate variance, cov-
ariance, and correlation which are of particular interest in
familial studies. In this paper, multilevel models are first
used to fit the repeated systolic blood pressure (SBP)
measurements. Residuals from the subject-specific and
pedigree-specific regression models were summed both
for the mean SBP and slope of SBP change over time, in
order to define two new outcomes that were then used in
a genome-wide linkage analysis. Both phenotypes are of
interest because genes involved in the variation of SBP
with time could differ from genes affecting long-term
mean SBP.
Methods
Data
The Framingham Heart Study data includes 330 pedigrees
originally selected for a genome-scan analysis. The pedi-
grees consisted of 4692 subjects, of whom 2885 have par-
ticipated in the Framingham Heart Study. Longitudinal
SBP data were analyzed for 25,263 examinations on 2662
individuals. Height, weight, gender, age, and hypertensive
treatment information were required but if height was
missing, the most recent measurement was imputed.
Because there might be important variation in individual
SBP measurement among younger and older subjects, we
also restricted the sample to individuals aged between 25
and 75 years, as in Levy et al. [2]. The following selection
criteria were also defined: 1) There had to be at least 10
years between a subject's initial and final examinations
within the age range; 2) at least four examinations within
the age range were required for the original cohort and at
least three for offspring cohort participants [2]. Data from
24,840 examinations on 2530 individuals were available
in the selected sample. For the genome-wide scan analy-
sis, 1702 genotyped individuals were included (394 from
the Cohort 1 and 1308 from the Cohort 2).
Multilevel analysis of the longitudinal SBP model
Let the random variable Yijk denote the SBP measurement
at the ith examination for the jth individual in pedigree k.
We then assume that Yijk satisfies the following general
multilevel model:
Within-subject model – Level 1
where i = 1,...,21 for Cohort 1 subjects and i = {11, 15, 17,
19, 21} for Cohort 2 subjects. Ageijk, BMIijk, Treatijk are the
age, body mass index and hypertension treatment (1 for
subjects treated and 0 for subjects untreated) at the ith
exam for the jth individual in pedigree k,   and 
are the mean values across all exams for the jth individual,
and  εijk are the error components that account for the
within-individual variability. The εijk are assumed to be
normally distributed with mean vector zero and variance-
covariance matrix Σ defined by a first-order autoregressive
structure. The intercept b0jk represents the average SBP for
an untreated subject of average age and BMI across all of
the subject's examinations. The regression coefficient b1jk
is used to model the linear variation of SBP with age. We
found that every individual profile could be well approxi-
mated by a quadratic function of time, measured by the
age at examination. We also tested a cubic effect, but it was
not significant when we allowed for the individual's linear
time trend to differ in each treatment group (interaction
between age and treatment). Random effects were added
to reflect the natural heterogeneity in the population. In
this model, both the intercept and the linear effect for age
were allowed to vary across individuals and the individ-
ual-specific regression coefficients (random effects) were
defined at the second level:
Subject random-intercept model – Level 2
Subject random-slope model – Level 2
 and   are the sample means for age and body
mass index, Sex and Cohort are two indicator variables,
coded 1 for males, 0 for females and 0 for Cohort 1 sub-
jects, 1 for Cohort 2 subjects. The random components
u0jk and  u1jk measure the variation of each individual's
mean SBP and slope from their average in pedigree k. The
intercept b00k represents the average SBP in pedigree k for
males in Cohort 1 with average age and BMI and the inter-
cept b10k represents the average slope in pedigree k  for
males in Cohort 1 with average BMI. To account for the
correlation of individuals within a pedigree, these two
intercepts were allowed to vary between pedigrees. The
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random effects at different levels of the model are
assumed independent.
Pedigree random-intercept model – Level 3
b00k = β000 + v00k, k = 1,...,N
Pedigree random-slope model – Level 3
The random components v00k and v01k measure the varia-
tion of each pedigree's mean SBP and mean slope from
their average in the whole sample.
Statistical tests in the multilevel model
Analyses were conducted in both the unselected and
selected samples and with and without adjustment for
BMI. Multilevel models were fitted using SAS PROC
MIXED [3]. Parameter estimates are obtained by restricted
maximum likelihood estimation (REML). An F-statistic
was used to test the significance of the fixed effects with
number of degrees of freedom computed using the con-
tainment method [4]. The likelihood ratio statistic based
on REML likelihoods was used to test the significance of
the random effects. The null distribution of this statistic is
a mixture of   and   with equal weights 0.5, where
q and q + 1 are the number of random effects estimated
under H0 and H1, respectively.
Genome-wide linkage analysis
We used the estimates of the random effects at the subject
and pedigree levels to define two new outcomes that were
Table 1: Estimates of multilevel model fixed effects and random effects variances (± SE) in the selected and unselected samples with or 
without adjustment for BMI
Unselected Sample Selected Sample
Adjusted (1a) Unadjusted (1b) Adjusted (2a) Unadjusted (2b)
Fixed effects estimates
Intercept 132.46 (0.56)*** 132.00 (0.57)*** 131.16 (0.58)*** 131.80 (0.59)***
Age effectA 0.60 (0.02)*** 0.63 (0.02)*** 0.61 (0.02)*** 0.63 (0.02)***
Age2 effectA 0.013 (0.001)*** 0.010 (0.001)*** 0.014 (0.001)*** 0.001 (0.001)***
BMI effectA 1.45 (0.05)*** - 1.4 (0.05)*** -
Treat effect -2.13 (0.42)*** -1.45 (0.43)*** -2.2 (0.43)*** -1.52 (0.44)***
Age * Treatment effect -0.35 (0.04)*** -0.34 (0.04)*** -0.34 (0.04)*** -0.34 (0.04)***
Subject random intercept 
model
Mean age effectA 0.53 (0.03)*** 0.65 (0.03)*** 0.62 (0.04)*** 0.72 (0.04)***
Mean BMI effectA 1.16 (0.06)*** - 1.21 (0.07)*** -
Cohort effect                          -6.56 (0.67)*** -5.21 (0.70)*** -5.74 (0.71)*** -4.68 (0.74)***
Gender effect 2.27 (0.51)*** 3.59 (0.53)*** 1.71 (0.53)*** 3.09 (0.56)***
Subject random slope 
model
Mean BMI effectA -0.014 (0.003)*** - -0.015 (0.003)*** -
Cohort effect                          -0.46 (0.03)*** -0.29 (0.03)*** -0.42 (0.03)*** -0.27 (0.03)***
Gender effect -0.03 (0.03) -0.07 (0.03)* -0.04 (0.03) -0.08 (0.03)**
Covariance Parameter 
Estimates
Measurement error 
variance
140.85 (1.64)*** 148.11 (1.73)*** 141.80 (1.68)*** 149.01 (1.77)***
AR(1) correlation 0.25 (0.01)*** 0.26 (0.01)*** 0.25 (0.01)*** 0.26 (0.01)***
Subject level var(u0jk) 146.25 (5.01)*** 161.79 (5.49)*** 147.63 (5.30)*** 164.31 (5.84)***
var(u1jk) 0.17 (0.01)*** 0.20 (0.01)*** 0.17 (0.01)*** 0.20 (0.01)***
cov(u0jk, u1jk) 1.41 (0.19)*** 0.85 (0.21)*** 1.42 (0.20)*** 0.86 (0.22)***
Pedigree level var(v00k) 27.59 (4.17)*** 24.41 (4.07)*** 27.04 (4.31)*** 23.22 (4.13)***
var(v01k) 0.008 (0.005)* 0.005 (0.005) 0.009 (0.005)* 0.006 (0.005)
cov(v00k, v01k) 0.52 (0.12)*** 0.37 (0.11)** 0.49 (0.12)*** 0.37 (0.12)**
-2 REML 202,695.75 205,876.11 194,947.18 198,006.24
AVariables centered * p < 0.05 ** p < 0.01 *** p < 0.001
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used in the genome-wide linkage analysis. The two out-
comes were defined as   and  , which
measure the random variation of each individual's SBP
mean and slope, respectively, from the sample average
after adjustment for the fixed effects. A third outcome was
also defined using the residuals from a sample-wide
regression in which each individual's mean SBP (across all
exams) was regressed on his mean age (centered), mean
BMI (centered), gender and cohort, as in Levy et al.'s paper
[2]. Estimation of heritability and two-point linkage anal-
yses were performed on the pedigree data using the vari-
ance component models implemented in the SOLAR
package [5].
Results
Multivariate analysis of longitudinal SBP
All fixed effects included in the model were highly signif-
icant in the subject random slope model (Table 1) except
for gender. Most of the SBP variability (316.8 in Model 1a,
Table 1) was explained by within-subject (140.8, 44%)
and between-subject (146.2, 46%) variability in the mean
SBP and to a lesser extent by between-pedigree variability
(27.6, <9%). Much less variability was explained by varia-
bility in the slope (0.17+0.008, <0.06%). Pedigree effects
of mean SBP and SBP slope were more significant when
the multilevel analyses were adjusted for body mass
index. As shown in Figure 1, the multilevel model fit well
Comparisons of observed SBP and predicted values for the selected sample Figure 1
Comparisons of observed SBP and predicted values for the selected sample A, B, D, E are based on the multilevel 
model. C and F are based on the sample-wide regression for the selected sample [2].
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the data while the sample-wide regression does not cap-
ture all the SBP variability.
Heritability
Heritability estimates were 54.3% (SE = 3.1) and 55.6%
(SE = 3.4) for the mean SBP, 31.9% (SE = 3.5) and 28.9%
(SE = 3.5) for SBP slope over time in the unselected and
selected samples, respectively. The heritability estimates
for the subject-specific residuals from the sample-wide
regression of the mean SBP were 47.7% (SE = 3.4) and
49.7% (SE = 3.8) in the unselected and selected samples,
respectively.
Genome-wide linkage analysis
Evidence for linkage for the two outcomes (mean SBP and
slope) was found in several chromosomal regions with a
maximum LOD score of 3.6 on chromosome 8 and 3.5 on
chromosome 17 for the mean SBP and 2.5 on chromo-
some 1 for SBP slope (Table 2). However, linkage on chro-
mosome 8 for the mean SBP was only found in the
selected sample. The decrease in LOD score in the unse-
lected sample on chromosome 17 was important in sev-
eral pedigrees that included individuals with a single SBP
measurement, as illustrated in Figure 2. Adjusting the
analyses for BMI showed stronger evidence for linkage,
which could suggest that BMI is determined by other
genetic factors (Table 3). Not adjusting the analysis for
treatment effect did not change the results of the mean
SBP, but yielded lower LOD scores for SBP slope (Table
3).
Discussion
Our study demonstrates the value of multilevel modeling
in the search for genetic determinants of complex traits
when longitudinal pedigree data are available. For the
mean SBP, we were able to replicate the linkage result on
chromosome 17 previously reported by Levy et al. [2] and
detect a new linkage on chromosome 8 that was not
reported before. For SBP slope, we also found suggestive
results for linkage for both mean SBP and SBP slope on
several other chromosomal regions, including chromo-
somes 1, 2, 3, 11, and 13. Using residuals from the multi-
level model in a genome-wide linkage analysis gave
stronger evidence for linkage than using residuals from a
sample-wide regression as in the Levy et al.'s paper [2].
This might be because this latter approach does not cor-
rectly account for within-individual and between-individ-
ual variability. Multilevel modeling, which can take into
Table 2: Results of two-point linkage analysis (LOD scores ≥ 2 are in bold)
Unselected Sample Selected Sample
Markers Location Mean SBP
Multilevel 
Model
Mean SBPA 
Sample-
wide 
Regression
SBP slope
Multilevel 
Model
Mean SBP
Multilevel 
Model
Mean SBPA 
Sample-
wide 
Regression
SBP slope
Multilevel 
Model
GATA48B01 1 (212 cM) 0.30 0.23 2.00 0.30 0.21 2.47
GATA11H10 2 (38 cM) 1.47 1.36 0 2.32 2.20 0.18
GATA6F06 3 (79cM) 2.16 1.78 0 1.17 0.81 0.14
GATA4A10 3 (153 cM) 0.31 0.21 2.27 0.33 0.31 1.29
GATA72C10 8 (37 cM) 3.57 2.54 1.00 3.57 2.82 1.71
ATA34E08 11 (33 cM) 0.16 0.11 2.13 0.03 0.01 1.54
GATA7G10 13 (64 cM) 2.02 1.92 0 1.79 1.63 0
GATA25A04 17 (62 cM) 2.13 1.78 0 3.54 3.42 0
AResiduals from the sample-wide regression of the mean SBP on the mean age, mean BMI, gender, and cohort effects as in Levy et al. [2].
Observed and predicted SBP profiles for pedigree 32,445  members Figure 2
Observed and predicted SBP profiles for pedigree 32,445 
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account the hierarchical structure of the data, may help
disentangle the proportion of the trait variability
explained by fundamental variation in the mean SBP and
in the SBP slope from the proportion explained by ran-
dom within-individual variability. A more general hierar-
chical structure could have included a nuclear family level
nested within the pedigree level. However, such a multi-
level model would be more difficult to fit. In our analysis
we only included a fixed cohort effect that could account
for differences between generations within a pedigree.
Treating the pedigrees as random effects also allowed for
between-pedigree heterogeneity in our model, which
improved the accuracy of the random effect estimates at
the individual level. Although there may be some concern
about using a two-stage approach for detecting linkage,
other studies based on similar strategies using linear
mixed models in simulated data did not report an infla-
tion of type I error for the test of linkage in the context
genome-wide linkage analysis [6,7]. The linkage on chro-
mosome 17 for mean SBP was only found in the selected
sample. A important decrease in LOD score (>0.1) in the
unselected sample was observed in several pedigrees com-
prising individuals with a single extreme SBP measure-
ment, as illustrated in Figure 2. This suggests that a single
SBP measurement may not provide a reliable characteriza-
tion for an individual, especially when a familial study of
SBP is designed. Adjusting the analyses for BMI showed
stronger evidence for linkage, which could suggest that
BMI is determined by other genetic factors. No correction
was applied to the SBP value of subjects who received a
hypertensive treatment. The analyses with the multilevel
model were adjusted for treatment effect so that the resid-
uals obtained from this model correspond to the
untreated group. Taking into account an interaction
between age and treatment in the multilevel model may
also have reduced the bias due to treatment effect. How-
ever, our linkage results were insensitive to whether the
analyses were adjusted for treatment effect. The multilevel
modeling approach is also known to be robust to missing
data, under the assumption that they are missing at ran-
dom [4]. Future work could include the development of
an integrated approach to perform linkage analysis within
the multilevel framework.
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